Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Increasing Equitable Adherence to Annual Lung Cancer Screening and Diagnostic Follow-up

NCT05832008 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT05832008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05832008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Increasing Equitable Adherence to Annual Lung Cancer Screening and Diagnostic Follow-up
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Not applicable
Overall status
Completed
Start date
October 18, 2023
Completion date
February 28, 2026
Enrollment
825 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adherence, patient, lung cancer